The study is a prospective randomized controlled trial comparing the efficacy and safety of propofol-ketamine ("Ketofol") versus propofol monotherapy in geriatric ICU patients. Eligible participants are critically ill elderly patients with a history of cardiac disease who require endotracheal intubation and have not yet received sedation. The investigators focus on a specific population in which geriatric patients have different pharmacokinetics and pharmacodynamics and are more prone to side effects than other populations. Primary outcome: Incidence of hemodynamic instability (defined as hypotension requiring vasopressors), measured by mean arterial pressure (MAP) at baseline, during intubation, and post-intubation at 1, 3, 5, 10, 20, 30, and 60 minutes, then hourly for 24 hours.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
41
Patients will take bolus dose of Propofol 0.25 mg/kg + Ketamine 0.25mg/kg If patient NOT sedated and need additional doses will be given another Propofol 0.25 mg/kg + Ketamine 0.25mg/kg IV
Propofol given normal doses for intubation but at reduced and gradual dosing regimen regarding geriatric patient
Badr University hospital in Cairo
Cairo, Cairo Governorate, Egypt
Mean arterial blood pressure
hemodynamic stability, defined as MAP measured Baseline then during and post intubation at 1min , 3min , 5min 10min, 20min , 30min , 60min then hourly for 24h.
Time frame: baseline then at 1, 3, 5, 10, 20, 30, and 60 minutes, then hourly for 24 hours
Time to successful intubation
Time to successful intubation (from induction to tube placement confirmation
Time frame: within 1 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.